View More
Juan Frias and Philip Newsome: available approaches to managing NASH, including lifestyle and vitamin E, and compounds that target insulin resistance
Juan Pablo Frias, MD, FACE
Philip N. Newsome, PhD, FRCPE
Released: December 13, 2019
Rita Basu, MD, and Stephen A. Harrison, MD, COL (Ret.), FAASLD, on wet biomarkers, imaging, and combination tests for NAFLD and NASH
Rita Basu, MD
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: December 6, 2019
Hear Kenneth Cusi, MD, FACP, FACE, explore NASH screening and interplay among NAFLD, metabolic syndrome, CV risk, diabetes risk
Kenneth Cusi, MD, FACP, FACE
Released: December 5, 2019
CCO faculty Paul Kwo, MD, answers FAQs in hepatitis B management including treatment candidacy and duration
Paul Y. Kwo, MD
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.